The 2019 American Academy of Neurology Meeting was held from May 4th to 11th in Philadelphia, Pennsylvania.
The AAN meeting focused on various Myasthenia Gravis types and their classification, available treatment options, and resources to measure disease severity. This issue of CARE™ Perspectives from AAN provides updates on key news along with insights from a recent CARE™ Needs Assessment on MG.
The content that follows is written in the language in which it was presented and is adapted from the abstracts of the AAN 2019 meeting.
CARE™ Neurology Faculty who have contributed to this report:
Dr. Vera Bril
Toronto General Hospital